Mainegeneral Medical Center

Mainegeneral Medical Center was paid $167.78M by Medicaid between Jan 2018 and Dec 2024, across 812 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 28% of everything it billed.

33Billing provider infoMAINEGENERAL MEDICAL CENTER
AUGUSTA, ME 04330

33aNPI1669423380assigned 05/15/2006

33bProvider typeGeneral Acute Care Hospital

28Total paid$167.78M

24GClaims4,791,823

24DCodes billed812

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in Maine

Rank by total paid#1 of 33

Median peer was paid$4.34M

This provider vs. median39×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	588,103	$17.70M
2019	692,889	$21.73M
2020	617,137	$19.06M
2021	758,142	$25.23M
2022	744,698	$28.10M
2023	743,444	$28.39M
2024incomplete	647,410	$27.57M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0463	Hospital outpatient clinic visit for assessment and management of a patient	28%	716,216	525,350	$46.93M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	5.0%	83,176	76,559	$8.34M
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	5.0%	214,534	198,735	$8.32M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	4.6%	67,080	63,143	$7.71M
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	3.9%	241,726	222,773	$6.57M
J9271	Injection, pembrolizumab, 1 mg	3.9%	1,495	1,089	$6.47M
J3380	Injection, vedolizumab, intravenous, 1 mg	2.9%	1,277	1,210	$4.95M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	2.7%	18,116	16,237	$4.54M
74177	Computed tomography, abdomen and pelvis; with contrast material	1.3%	13,121	12,379	$2.18M
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	1.2%	19,729	17,430	$1.96M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	1.1%	19,858	11,942	$1.79M
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	1.1%	14,713	8,579	$1.79M

800 more codes

90853	Group psychotherapy (other than of a multiple-family group)	1.0%	38,349	$1.75M
78815	Positron emission tomography (PET) for limited area imaging	1.0%	3,234	$1.70M
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	7,530	$1.64M
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	4,242	$1.55M
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	24,928	$1.55M
99232	Hospital visit by a doctor, follow-up day	<1%	48,381	$1.33M
J1745	Injection, infliximab, excludes biosimilar, 10 mg	<1%	1,016	$1.33M
92012	Ophthalmological services: medical examination and evaluation, intermediate, established patient	<1%	23,873	$1.29M
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	63,159	$1.25M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	61,061	$1.23M
90837	Psychotherapy session, about an hour	<1%	16,416	$1.13M
77386		<1%	4,116	$1.10M
90847	Family psychotherapy with the patient present, 50 minutes	<1%	11,605	$1.09M
71046	Radiologic examination, chest; 2 views	<1%	30,432	$1.09M
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	82,972	$1.08M
90834	Psychotherapy session, about 45 minutes	<1%	13,705	$1.02M
99215	Doctor's office visit, returning patient (complex)	<1%	17,132	$1.01M
Q9991	Injection, buprenorphine extended-release (sublocade), less than or equal to 100 mg	<1%	602	$973K
90832	Psychotherapy session, about 30 minutes	<1%	16,428	$948K
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	2,990	$914K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	3,556	$861K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	2,639	$858K
J0585	Injection, onabotulinumtoxina, 1 unit	<1%	2,296	$836K
G0008	Administration of influenza virus vaccine	<1%	30,736	$830K
Q9992	Injection, buprenorphine extended-release (sublocade), greater than 100 mg	<1%	527	$827K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	8,458	$820K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	15,755	$806K
0225U		<1%	4,174	$777K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	1,868	$760K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	11,313	$759K
70450	Computed tomography, head or brain; without contrast material	<1%	9,373	$741K
90791	Psychiatric diagnostic evaluation	<1%	6,714	$705K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	20,957	$696K
96375	Therapeutic injection; each additional sequential IV push	<1%	20,089	$637K
96361	Intravenous infusion, hydration; each additional hour	<1%	19,110	$604K
J0897	Injection, denosumab, 1 mg	<1%	576	$597K
20610		<1%	5,587	$590K
96130		<1%	4,730	$560K
77412		<1%	5,257	$522K
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	<1%	9,005	$471K
92014	Ophthalmological services: medical examination and evaluation, comprehensive, established patient	<1%	9,470	$470K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	4,308	$430K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	27,428	$402K
77334		<1%	1,466	$389K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	5,815	$366K
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	<1%	6,819	$364K
95811		<1%	1,329	$358K
G0009	Administration of pneumococcal vaccine	<1%	11,382	$341K
J0185	Injection, aprepitant, 1 mg	<1%	2,538	$339K
97161		<1%	8,735	$337K
90846	Family psychotherapy without the patient present, 50 minutes	<1%	3,260	$333K
J7307	Etonogestrel (contraceptive) implant system, including implant and supplies	<1%	397	$329K
92004	Ophthalmological services: medical examination and evaluation, comprehensive, new patient	<1%	4,495	$327K
90792	Psychiatric diagnostic evaluation with medical services	<1%	4,130	$321K
43235		<1%	1,090	$303K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	21,373	$303K
80053	Comprehensive metabolic panel	<1%	156,872	$299K
52000		<1%	1,735	$280K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	7,814	$277K
94060		<1%	3,690	$273K
84443	Thyroid stimulating hormone (TSH)	<1%	49,314	$271K
76819	Fetal biophysical profile; without non-stress testing	<1%	3,076	$265K
11043		<1%	2,128	$260K
96367		<1%	6,589	$258K
86900		<1%	6,821	$255K
92557		<1%	5,263	$245K
80061	Lipid panel	<1%	33,746	$245K
J9299	Injection, nivolumab, 1 mg	<1%	146	$244K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	6,570	$243K
76830	Ultrasound, transvaginal	<1%	3,157	$238K
J2505	Injection, pegfilgrastim, 6 mg	<1%	141	$235K
90960	End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits	<1%	4,588	$234K
Q5104	Injection, infliximab-abda, biosimilar, (renflexis), 10 mg	<1%	138	$222K
93010	Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only	<1%	51,340	$218K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	<1%	4,084	$215K
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	<1%	304	$215K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	7,009	$213K
87811	Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19)	<1%	8,492	$212K
77336		<1%	3,871	$204K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	155,565	$204K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	7,393	$202K
66984	Extracapsular cataract removal with insertion of intraocular lens prosthesis	<1%	441	$202K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	14,697	$192K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	3,295	$190K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	4,927	$187K
99204	Doctor's office visit, new patient (more involved)	<1%	3,045	$180K
96131		<1%	4,223	$179K
99233	Hospital visit by a doctor, follow-up day (complex)	<1%	4,915	$178K
71275	Computed tomographic angiography, chest, with contrast material	<1%	2,314	$171K
G0010	Administration of hepatitis b vaccine	<1%	5,185	$171K
71250		<1%	4,536	$167K
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	<1%	3,366	$159K
77300		<1%	837	$159K
J2426	Injection, paliperidone palmitate extended release (invega sustenna), 1 mg	<1%	136	$156K
G0475	Hiv antigen/antibody, combination assay, screening	<1%	8,784	$152K
93971		<1%	3,001	$148K
96101		<1%	1,191	$148K
10060		<1%	1,329	$145K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	13,025	$144K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	12,950	$144K
99310	Prolong nursin fac eval 15m	<1%	5,751	$144K
93017		<1%	3,394	$138K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	4,485	$136K
64615		<1%	1,648	$136K
71045	Radiologic examination, chest; single view	<1%	4,215	$134K
76770		<1%	2,168	$134K
94726		<1%	5,083	$131K
96415		<1%	3,574	$126K
Q3014	Telehealth originating site facility fee	<1%	9,360	$123K
92060		<1%	10,573	$121K
G2212	Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99205, 99215, 99483 for office or other outpatient evaluation and management services) (do not report g2212 on the same date of service as 99358, 99359, 99415, 99416). (do not report g2212 for any time unit less than 15 minutes)	<1%	1,610	$121K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	6,338	$119K
36415	Collection of venous blood by venipuncture	<1%	196,326	$119K
97803		<1%	4,018	$118K
92552		<1%	1,730	$116K
70491		<1%	852	$116K
99203	Doctor's office visit, new patient (routine)	<1%	3,591	$115K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	1,312	$115K
90686		<1%	22,032	$113K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	7,646	$112K
93798		<1%	2,226	$112K
70496		<1%	684	$112K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	2,098	$111K
47562		<1%	40	$109K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	320	$105K
97162		<1%	3,394	$103K
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	33,992	$103K
76536		<1%	1,655	$96K
92002		<1%	1,238	$95K
93880		<1%	1,365	$95K
96417		<1%	3,344	$94K
83036	Hemoglobin; glycosylated (A1C)	<1%	36,958	$94K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	43,932	$93K
J0178	Injection, aflibercept, 1 mg	<1%	81	$92K
72100		<1%	4,041	$92K
71271		<1%	1,793	$91K
G0399	Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation	<1%	1,462	$91K
74018		<1%	4,660	$90K
97597		<1%	1,862	$88K
76642		<1%	1,953	$85K
95004	Percutaneous tests with allergenic extracts, immediate type reaction	<1%	2,406	$83K
20553		<1%	773	$81K
90677		<1%	2,140	$80K
11102		<1%	1,139	$80K
73630		<1%	7,228	$80K
11721		<1%	13,286	$80K
Q5107	Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg	<1%	66	$79K
73564		<1%	3,585	$79K
73030		<1%	6,720	$78K
91200		<1%	1,363	$78K
92588		<1%	420	$78K
20611		<1%	623	$77K
J7298	Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg	<1%	102	$77K
93970		<1%	700	$77K
86780		<1%	7,001	$75K
17110		<1%	2,485	$75K
99222	Initial hospital care, per day, moderate complexity	<1%	1,240	$73K
88142		<1%	6,220	$71K
77063	Screening digital breast tomosynthesis, bilateral	<1%	7,132	$70K
20550		<1%	494	$69K
J2357	Injection, omalizumab, 5 mg	<1%	47	$69K
73610		<1%	5,565	$69K
99223	Prolong inpt eval add15 m	<1%	1,065	$68K
Q0091	Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory	<1%	4,026	$66K
99205	Prolong outpt/office vis	<1%	696	$66K
J9035	Injection, bevacizumab, 10 mg	<1%	36	$64K
76882		<1%	1,296	$63K
J1453	Injection, fosaprepitant, 1 mg	<1%	407	$63K
99239	Hospital discharge day management, more than 30 minutes	<1%	1,273	$62K
95117		<1%	2,223	$61K
77080		<1%	1,838	$61K
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	<1%	950	$60K
88184		<1%	476	$59K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	533	$59K
87522	Neg quan hep c or qual rna	<1%	2,591	$59K
77066	Tomosynthesis, mammo	<1%	1,084	$57K
94010		<1%	4,653	$57K
97165		<1%	1,474	$55K
95115		<1%	2,091	$54K
86003		<1%	1,727	$53K
31575		<1%	709	$52K
77301		<1%	112	$52K
82607		<1%	9,630	$51K
76801		<1%	583	$50K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	922	$50K
99496		<1%	1,008	$50K
G0101	Cervical or vaginal cancer screening; pelvic and clinical breast examination	<1%	1,011	$49K
97163		<1%	974	$49K
87086	Culture, bacterial; quantitative colony count, urine	<1%	25,456	$48K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	3,935	$48K
85027		<1%	22,364	$47K
64483		<1%	122	$47K
82728		<1%	10,948	$47K
73110		<1%	3,608	$47K
73130		<1%	4,033	$47K
99231	Subsequent hospital care, per day, straightforward or low complexity	<1%	3,154	$46K
Q0138	Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)	<1%	361	$45K
80048	Basic metabolic panel (calcium, ionized)	<1%	24,130	$44K
77290		<1%	352	$44K
73562		<1%	4,464	$44K
70486		<1%	1,101	$42K
84702		<1%	6,922	$42K
90651		<1%	4,530	$42K
29581		<1%	453	$41K
99358	Prolong nursin fac eval 15m	<1%	790	$39K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	24,019	$39K
83655		<1%	4,872	$38K
87536		<1%	1,269	$38K
93225		<1%	625	$37K
67028	Intravitreal injection of a pharmacologic agent	<1%	753	$37K
99308	Subsequent nursing facility care, per day, straightforward	<1%	3,119	$37K
96411		<1%	1,301	$36K
98927		<1%	5,361	$36K
96136		<1%	4,643	$36K
36561		<1%	25	$36K
99426		<1%	557	$35K
73140		<1%	2,708	$35K
92567		<1%	10,113	$34K
G0472	Hepatitis c antibody screening, for individual at high risk and other covered indication(s)	<1%	4,337	$34K
84439		<1%	11,723	$34K
99454		<1%	2,270	$33K
80074		<1%	2,051	$33K
73502		<1%	2,961	$32K
64721		<1%	40	$32K
87510		<1%	3,183	$32K
87480		<1%	3,183	$31K
87660		<1%	3,183	$31K
90480		<1%	1,826	$31K
86480		<1%	868	$31K
H0041	Foster care, child, non-therapeutic, per diem	<1%	27	$31K
90670		<1%	8,208	$31K
72040		<1%	1,891	$31K
84403		<1%	2,220	$30K
83970		<1%	2,700	$30K
62323		<1%	134	$30K
90732		<1%	676	$30K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	446	$30K
11100		<1%	293	$30K
97802		<1%	488	$29K
96150		<1%	690	$29K
93923		<1%	665	$28K
12001		<1%	1,206	$28K
83550		<1%	10,773	$28K
91320		<1%	806	$28K
73560		<1%	2,892	$28K
93016		<1%	2,618	$27K
77280		<1%	517	$27K
83540		<1%	12,593	$26K
83516		<1%	4,506	$26K
91322		<1%	616	$26K
72110		<1%	709	$26K
73100		<1%	1,484	$25K
97166		<1%	931	$25K
99495		<1%	534	$25K
82746		<1%	4,705	$24K
J1750	Injection, iron dextran, 50 mg	<1%	197	$24K
D1206	Topical application of fluoride varnish	<1%	2,029	$24K
96152		<1%	674	$23K
96110	Developmental screening, with scoring and documentation, per standardized instrument	<1%	3,244	$23K
86140		<1%	18,777	$23K
77065	Tomosynthesis, mammo	<1%	644	$23K
51705		<1%	480	$23K
58301		<1%	127	$23K
72125	Computed tomography, cervical spine; without contrast material	<1%	3,431	$22K
97116		<1%	3,041	$22K
86618		<1%	4,344	$21K
J0881	Injection, darbepoetin alfa, 1 microgram (non-esrd use)	<1%	171	$21K
97035		<1%	4,336	$21K
96910		<1%	784	$21K
76870		<1%	550	$20K
51702		<1%	1,398	$20K
0002A		<1%	599	$20K
87186		<1%	9,997	$20K
43249		<1%	31	$20K
0001A		<1%	618	$20K
87081		<1%	9,020	$20K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	2,101	$20K
36430		<1%	165	$19K
99177		<1%	2,571	$19K
96158		<1%	989	$19K
78264		<1%	102	$19K
58300		<1%	460	$18K
82105		<1%	2,394	$18K
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	2,669	$18K
87340		<1%	5,423	$18K
11056		<1%	729	$18K
90746		<1%	310	$18K
83735		<1%	32,683	$17K
99221		<1%	433	$17K
90961		<1%	462	$17K
96127		<1%	3,496	$17K
95816		<1%	631	$17K
86762		<1%	3,419	$16K
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	1,491	$16K
70498		<1%	667	$16K
11046		<1%	144	$16K
73080		<1%	1,438	$16K
82784		<1%	4,369	$16K
93308		<1%	125	$16K
94762		<1%	318	$16K
96137		<1%	3,301	$16K
93922		<1%	791	$16K
G0297	Low dose ct scan (ldct) for lung cancer screening	<1%	848	$16K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	889	$15K
97535	Self-care/home management training, each 15 minutes	<1%	1,592	$15K
83880		<1%	6,341	$15K
77338		<1%	118	$15K
72050		<1%	420	$15K
90661		<1%	864	$15K
J2997	Injection, alteplase recombinant, 1 mg	<1%	74	$14K
73590		<1%	1,426	$14K
0064A		<1%	1,020	$14K
99238	Hospital discharge day management, 30 minutes or less	<1%	357	$14K
80076		<1%	4,188	$14K
99188		<1%	1,080	$13K
86706		<1%	2,953	$13K
98928		<1%	3,375	$13K
82570		<1%	9,177	$13K
86038		<1%	2,556	$13K
85610		<1%	35,171	$13K
99406		<1%	868	$12K
90716		<1%	2,672	$12K
81001		<1%	38,805	$12K
74178		<1%	72	$12K
87427		<1%	2,162	$12K
97167		<1%	361	$12K
92015	Determination of refractive state	<1%	6,702	$12K
74174		<1%	79	$11K
90870		<1%	52	$11K
11055		<1%	572	$11K
77295		<1%	27	$11K
0124A		<1%	852	$11K
88342		<1%	4,721	$11K
J1097	Phenylephrine 10.16 mg/ml and ketorolac 2.88 mg/ml ophthalmic irrigation solution, 1 ml	<1%	427	$11K
73090		<1%	879	$11K
92523		<1%	84	$11K
86666		<1%	3,053	$11K
17000		<1%	1,725	$11K
87905		<1%	4,118	$11K
98926		<1%	2,742	$10K
0004A		<1%	574	$10K
85652		<1%	12,224	$10K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	155	$10K
82785		<1%	1,687	$10K
87077		<1%	9,269	$10K
80164		<1%	2,646	$10K
72070		<1%	461	$10K
93793		<1%	4,009	$10K
84146		<1%	993	$10K
87808		<1%	3,928	$10K
82043		<1%	6,871	$9K
81025		<1%	20,100	$9K
83690		<1%	19,574	$9K
G0105	Colorectal cancer screening; colonoscopy on individual at high risk	<1%	27	$9K
83993		<1%	682	$9K
0003A		<1%	326	$9K
80178		<1%	3,306	$9K
90620		<1%	499	$8K
64493		<1%	31	$8K
86704		<1%	2,052	$8K
90662		<1%	2,623	$8K
M0243	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring	<1%	80	$8K
C9447	Injection, phenylephrine and ketorolac, 4 ml vial	<1%	143	$8K
80159		<1%	1,576	$8K
94729		<1%	5,070	$8K
52310		<1%	12	$8K
86850		<1%	7,108	$7K
84425		<1%	704	$7K
83001		<1%	844	$7K
87070		<1%	5,222	$7K
73501		<1%	963	$7K
82947		<1%	2,245	$7K
96112		<1%	49	$7K
96156		<1%	201	$7K
99427		<1%	174	$7K
69209		<1%	2,832	$7K
86803		<1%	1,294	$7K
99359	Prolong nursin fac eval 15m	<1%	220	$7K
87147		<1%	3,110	$7K
72170		<1%	497	$7K
99309	Subsequent nursing facility care, per day, low to moderate complexity	<1%	395	$7K
92134		<1%	1,898	$6K
0081A		<1%	156	$6K
86200		<1%	1,324	$6K
90619		<1%	1,060	$6K
87205		<1%	8,482	$6K
84153		<1%	1,722	$6K
11730		<1%	82	$6K
96161		<1%	209	$6K
0011A		<1%	217	$6K
96523		<1%	324	$5K
73700		<1%	89	$5K
84100		<1%	7,175	$5K
93242		<1%	226	$5K
86753		<1%	1,597	$5K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	190	$5K
90734		<1%	3,446	$5K
69210		<1%	927	$5K
36593		<1%	52	$5K
87045		<1%	1,144	$5K
86255		<1%	803	$5K
G0499	Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result	<1%	357	$5K
74160		<1%	39	$5K
82950		<1%	1,124	$5K
86430		<1%	2,113	$5K
0012A		<1%	196	$5K
64450		<1%	25	$5K
86617		<1%	752	$5K
99173		<1%	2,327	$5K
88307		<1%	1,032	$4K
97150	Therapeutic procedure(s), group (2 or more individuals)	<1%	2,485	$4K
91010		<1%	25	$4K
0134A		<1%	370	$4K
11981		<1%	79	$4K
84165		<1%	1,940	$4K
74230		<1%	89	$4K
90688		<1%	433	$4K
G0121	Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk	<1%	13	$4K
87902		<1%	66	$4K
11750		<1%	20	$4K
J9217	Leuprolide acetate (for depot suspension), 7.5 mg	<1%	26	$4K
98929		<1%	1,024	$4K
P9040	Red blood cells, leukocytes reduced, irradiated, each unit	<1%	52	$4K
86787		<1%	690	$4K
85018		<1%	5,271	$4K
96402		<1%	664	$4K
82533		<1%	2,405	$4K
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established)	<1%	5,910	$4K
82550		<1%	4,966	$3K
J7323	Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose	<1%	70	$3K
84481		<1%	412	$3K
83615		<1%	8,382	$3K
0082A		<1%	79	$3K
0154A		<1%	147	$3K
73522		<1%	146	$3K
82565		<1%	4,108	$3K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	7,206	$3K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	148	$3K
86360		<1%	428	$3K
82248		<1%	1,176	$3K
81514		<1%	1,960	$3K
84156		<1%	2,239	$3K
73620		<1%	533	$3K
86481		<1%	84	$3K
82024		<1%	2,068	$3K
99460		<1%	49	$3K
84402		<1%	244	$3K
99442		<1%	582	$3K
88108		<1%	706	$3K
84550		<1%	2,216	$3K
86160		<1%	292	$3K
93976		<1%	38	$3K
87329		<1%	413	$3K
86359		<1%	456	$3K
78306		<1%	26	$3K
82670		<1%	169	$3K
85730		<1%	3,885	$3K
96160		<1%	81	$3K
77470		<1%	13	$2K
81003		<1%	23,898	$2K
96113		<1%	49	$2K
85379		<1%	4,748	$2K
73600		<1%	200	$2K
64400		<1%	15	$2K
86696		<1%	183	$2K
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	<1%	34	$2K
87328		<1%	317	$2K
96116		<1%	27	$2K
80305		<1%	2,245	$2K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	23,289	$2K
82378		<1%	1,916	$2K
85014		<1%	2,368	$2K
99350	Prolong home eval add 15m	<1%	99	$2K
86708		<1%	438	$2K
99462		<1%	74	$2K
29125		<1%	612	$2K
J2704	Injection, propofol, 10 mg	<1%	25,210	$2K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	16,829	$2K
86580		<1%	193	$2K
96121		<1%	25	$2K
92555		<1%	1,246	$2K
96132		<1%	12	$2K
74220		<1%	26	$2K
73000		<1%	85	$2K
86694		<1%	155	$2K
82140		<1%	678	$2K
11982		<1%	13	$2K
82103		<1%	457	$2K
0031A		<1%	65	$2K
12002		<1%	204	$2K
17250		<1%	18	$1K
84484		<1%	19,287	$1K
86695		<1%	183	$1K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	26,986	$1K
88304		<1%	1,808	$1K
73070		<1%	105	$1K
95909		<1%	14	$1K
87040		<1%	4,871	$1K
84460		<1%	534	$1K
87449		<1%	368	$1K
90935	Hemodialysis procedure with single evaluation by a physician	<1%	70	$1K
70355		<1%	45	$1K
87075		<1%	765	$1K
29515		<1%	17	$1K
86364		<1%	207	$1K
0073A		<1%	30	$1K
81511		<1%	12	$1K
11104		<1%	17	$1K
90833	Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on)	<1%	109	$1K
72114		<1%	26	$1K
12011		<1%	84	$1K
87324		<1%	330	$1K
80175		<1%	238	$1K
0071A		<1%	28	$1K
95806		<1%	26	$1K
J7030	Infusion, normal saline solution , 1000 cc	<1%	26,747	$1K
64405		<1%	14	$1K
99306	Prolong nursin fac eval 15m	<1%	39	$1K
77399		<1%	14	$1K
92551		<1%	157	$1K
83002		<1%	95	$1K
87478		<1%	119	$999.89
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	20,294	$987.20
86376		<1%	108	$977.48
86235		<1%	62	$964.20
73660		<1%	106	$922.29
83520		<1%	149	$920.94
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	17	$910.00
82150		<1%	1,042	$902.81
0083A		<1%	21	$891.24
87102		<1%	569	$890.92
99443		<1%	86	$888.23
83883		<1%	652	$885.37
87400		<1%	3,021	$876.34
0173A		<1%	36	$865.45
51798		<1%	2,086	$822.13
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	18,616	$817.24
86765		<1%	97	$802.01
90653		<1%	273	$794.86
73120		<1%	44	$784.37
82247		<1%	233	$768.66
97810		<1%	69	$767.08
99336		<1%	26	$764.41
74022		<1%	101	$748.61
87484		<1%	119	$722.70
87469		<1%	119	$722.39
87468		<1%	119	$722.39
85045		<1%	678	$720.65
86308		<1%	1,303	$714.91
98925		<1%	248	$693.13
86705		<1%	72	$659.12
87430		<1%	2,167	$658.56
64447		<1%	80	$651.38
86735		<1%	81	$633.93
90744		<1%	4,571	$626.74
96377		<1%	142	$606.76
96159		<1%	115	$583.59
70030		<1%	16	$579.17
82542		<1%	154	$559.84
80197		<1%	187	$548.01
93243		<1%	13	$545.27
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	26,573	$541.58
0034A		<1%	32	$527.02
95886		<1%	210	$489.59
92133		<1%	438	$477.23
74019		<1%	43	$473.13
51784		<1%	15	$470.11
80156		<1%	113	$444.26
86225		<1%	104	$443.12
86682		<1%	44	$429.14
J3490	Unclassified drugs	<1%	1,034	$424.60
90656		<1%	959	$418.00
93270		<1%	25	$417.02
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	5,757	$412.76
86920		<1%	266	$372.19
83605		<1%	5,103	$370.56
A4649	Surgical supply; miscellaneous	<1%	509	$364.94
87015		<1%	144	$357.10
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	14,865	$352.00
84132		<1%	475	$346.85
99334		<1%	24	$344.34
88187		<1%	17	$339.30
82010		<1%	858	$324.85
90680		<1%	5,925	$316.72
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	18,221	$313.28
99441		<1%	96	$310.63
11719		<1%	88	$306.80
94761		<1%	516	$305.04
81002		<1%	1,389	$303.58
82671		<1%	14	$290.70
86709		<1%	67	$285.53
82962		<1%	6,789	$283.27
92250		<1%	127	$278.22
86769		<1%	12	$274.42
86800		<1%	39	$271.72
82390		<1%	92	$263.93
82310		<1%	197	$256.11
80050	General health panel	<1%	15	$245.00
94664		<1%	1,719	$243.99
J2270	Injection, morphine sulfate, up to 10 mg	<1%	4,152	$235.45
83021		<1%	83	$234.78
72220		<1%	49	$234.09
92083		<1%	57	$231.35
G0283	Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care	<1%	164	$223.94
87338		<1%	29	$223.79
0013A		<1%	13	$223.50
J0736	Injection, clindamycin phosphate, 300 mg	<1%	313	$213.75
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	14	$200.70
87420		<1%	250	$199.07
71101		<1%	16	$191.42
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	1,440	$185.88
83020		<1%	84	$180.18
J0690	Injection, cefazolin sodium, 500 mg	<1%	7,308	$179.89
80069		<1%	54	$178.95
36600		<1%	31	$175.26
90715		<1%	10,221	$173.66
84480		<1%	29	$155.98
84450		<1%	68	$154.76
82803		<1%	951	$148.83
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	3,209	$147.76
86677		<1%	16	$147.30
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	7,397	$146.86
73060		<1%	15	$146.74
82951		<1%	12	$141.57
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	4,570	$140.36
92556		<1%	213	$129.12
J3480	Injection, potassium chloride, per 2 meq	<1%	956	$125.75
94375		<1%	13	$124.65
99348		<1%	19	$120.65
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	<1%	9,393	$116.57
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	9,267	$115.12
82985		<1%	26	$103.75
93226		<1%	498	$102.27
C1769	Guide wire	<1%	3,038	$102.26
82977		<1%	24	$94.79
36416		<1%	34,579	$92.44
83721		<1%	25	$84.43
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	2,221	$82.47
89051		<1%	527	$78.49
98968		<1%	22	$76.68
86901		<1%	6,821	$75.89
Q9957	Injection, perflutren lipid microspheres, per ml	<1%	2,515	$72.39
J1644	Injection, heparin sodium, per 1000 units	<1%	3,507	$63.56
C9290	Injection, bupivacaine liposome, 1 mg	<1%	1,417	$63.56
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	7,942	$60.29
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	16,301	$58.22
A9502	Technetium tc-99m tetrofosmin, diagnostic, per study dose	<1%	1,863	$57.32
J2785	Injection, regadenoson, 0.1 mg	<1%	1,314	$57.32
J1170	Injection, hydromorphone, up to 4 mg	<1%	4,192	$57.23
J1040	Injection, methylprednisolone acetate, 80 mg	<1%	2,266	$52.96
96376		<1%	3,379	$52.00
17003		<1%	241	$49.90
90472	Immunization administration, each additional vaccine (list separately)	<1%	19,630	$41.04
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	2,177	$40.63
92136		<1%	27	$37.36
84075		<1%	29	$37.33
G0476	Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test	<1%	362	$35.09
82952		<1%	12	$32.34
V2632	Posterior chamber intraocular lens	<1%	542	$28.13
G0143	Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with manual screening and rescreening by cytotechnologist under physician supervision	<1%	700	$27.85
83010		<1%	15	$25.16
J9045	Injection, carboplatin, 50 mg	<1%	839	$24.43
J7060	5% dextrose/water (500 ml = 1 unit)	<1%	5,276	$24.43
80177		<1%	12	$24.32
L4350	Ankle control orthosis, stirrup style, rigid, includes any type interface (e.g., pneumatic, gel), prefabricated, off-the-shelf	<1%	26	$24.00
84520		<1%	14	$23.86
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	3,236	$23.25
73552		<1%	14	$22.63
94760		<1%	1,883	$22.00
86301		<1%	16	$20.81
J1580	Injection, garamycin, gentamicin, up to 80 mg	<1%	715	$16.67
J8499	Prescription drug, oral, non chemotherapeutic, nos	<1%	1,456	$13.76
82040		<1%	25	$13.76
J1030	Injection, methylprednisolone acetate, 40 mg	<1%	1,777	$12.68
J3475	Injection, magnesium sulfate, per 500 mg	<1%	1,993	$11.78
96368		<1%	2,043	$11.78
88173		<1%	587	$9.96
85384		<1%	12	$8.68
82800		<1%	61	$8.66
82553		<1%	30	$7.92
J7050	Infusion, normal saline solution, 250 cc	<1%	6,796	$7.46
90474		<1%	5,877	$5.94
C9113	Injection, pantoprazole sodium, per vial	<1%	1,214	$5.25
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	2,602	$1.47
J1836	Injection, metronidazole, 10 mg	<1%	27	$0.21
A4216	Sterile water, saline and/or dextrose, diluent/flush, 10 ml	0%	24,361	$0.00
C1776	Joint device (implantable)	0%	440	$0.00
90633		0%	5,499	$0.00
99051		0%	1,788	$0.00
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	0%	1,016	$0.00
90707		0%	2,638	$0.00
A6212	Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing	0%	343	$0.00
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	0%	2,111	$0.00
90710		0%	2,638	$0.00
J1050	Injection, medroxyprogesterone acetate, 1 mg	0%	3,175	$0.00
J1756	Injection, iron sucrose, 1 mg	0%	770	$0.00
91300		0%	1,058	$0.00
G8984	Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals	0%	280	$0.00
87999		0%	44	$0.00
90713		0%	245	$0.00
93321		0%	314	$0.00
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	0%	2,342	$0.00
90700		0%	310	$0.00
G1004	Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program	0%	873	$0.00
99152		0%	2,648	$0.00
J0640	Injection, leucovorin calcium, per 50 mg	0%	691	$0.00
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	0%	582	$0.00
90685		0%	3,127	$0.00
J3370	Injection, vancomycin hcl, 500 mg	0%	1,137	$0.00
76942		0%	485	$0.00
J0780	Injection, prochlorperazine, up to 10 mg	0%	1,111	$0.00
J1650	Injection, enoxaparin sodium, 10 mg	0%	150	$0.00
J2919	Injection, methylprednisolone sodium succinate, 5 mg	0%	271	$0.00
84145		0%	39	$0.00
76937		0%	1,154	$0.00
J0694	Injection, cefoxitin sodium, 1 gm	0%	26	$0.00
J0171	Injection, adrenalin, epinephrine, 0.1 mg	0%	721	$0.00
88313		0%	225	$0.00
J1171	Injection, hydromorphone, 0.1 mg	0%	116	$0.00
77387		0%	154	$0.00
C1887	Catheter, guiding (may include infusion/perfusion capability)	0%	440	$0.00
J1953	Injection, levetiracetam, 10 mg	0%	15	$0.00
91321		0%	309	$0.00
G8985	Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	383	$0.00
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	699	$0.00
A9541	Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries	0%	218	$0.00
C1788	Port, indwelling (implantable)	0%	24	$0.00
80143		0%	56	$0.00
J3489	Injection, zoledronic acid, 1 mg	0%	13	$0.00
88104		0%	13	$0.00
J9190	Injection, fluorouracil, 500 mg	0%	286	$0.00
90648		0%	36	$0.00
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	0%	130	$0.00
A6021	Collagen dressing, sterile, size 16 sq. in. or less, each	0%	32	$0.00
J9263	Injection, oxaliplatin, 0.5 mg	0%	78	$0.00
90671		0%	44	$0.00
90380		0%	30	$0.00
J9060	Injection, cisplatin, powder or solution, 10 mg	0%	34	$0.00
G0500	Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate)	0%	123	$0.00
C1758	Catheter, ureteral	0%	44	$0.00
90649		0%	13	$0.00
80179		0%	51	$0.00
J2004	Injection, lidocaine hcl with epinephrine, 1 mg	0%	58	$0.00
L1830	Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf	0%	12	$0.00
96133		0%	12	$0.00
J1596	Injection, glycopyrrolate, 0.1 mg	0%	27	$0.00
A9270	Non-covered item or service	0%	1,327	$0.00
99153	Mod sedat endo service >5yrs	0%	1,963	$0.00
J2370	Injection, phenylephrine hcl, up to 1 ml	0%	1,948	$0.00
A9503	Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries	0%	120	$0.00
J1815	Injection, insulin, per 5 units	0%	522	$0.00
90696		0%	2,262	$0.00
J1630	Injection, haloperidol, up to 5 mg	0%	832	$0.00
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	0%	267	$0.00
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	0%	1,922	$0.00
90697		0%	292	$0.00
G8980	Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting	0%	220	$0.00
91306		0%	280	$0.00
J2060	Injection, lorazepam, 2 mg	0%	3,339	$0.00
C1781	Mesh (implantable)	0%	58	$0.00
90698		0%	8,190	$0.00
36000		0%	135	$0.00
J0500	Injection, dicyclomine hcl, up to 20 mg	0%	37	$0.00
G8986	Carrying, moving & handling objects functional limitation, discharge status, at discharge from therapy or to end reporting	0%	54	$0.00
88172		0%	87	$0.00
90636		0%	27	$0.00
G0378	Hospital observation service, per hour	0%	648	$0.00
J7999	Compounded drug, not otherwise classified	0%	52	$0.00
A6197	Alginate or other fiber gelling dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., each dressing	0%	241	$0.00
G8988	Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	143	$0.00
J2795	Injection, ropivacaine hydrochloride, 1 mg	0%	661	$0.00
88185		0%	295	$0.00
90632		0%	213	$0.00
J2470	Injection, pantoprazole sodium, 40 mg	0%	94	$0.00
G8987	Self care functional limitation, current status, at therapy episode outset and at reporting intervals	0%	100	$0.00
J1010	Injection, methylprednisolone acetate, 1 mg	0%	498	$0.00
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	0%	675	$0.00
G8982	Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	68	$0.00
J1940	Injection, furosemide, up to 20 mg	0%	404	$0.00
C1726	Catheter, balloon dilatation, non-vascular	0%	168	$0.00
J2003	Injection, lidocaine hydrochloride, 1 mg	0%	761	$0.00
88300		0%	13	$0.00
64494		0%	16	$0.00
J0461	Injection, atropine sulfate, 0.01 mg	0%	42	$0.00
77417		0%	69	$0.00
91301		0%	305	$0.00
C2617	Stent, non-coronary, temporary, without delivery system	0%	16	$0.00
74420		0%	63	$0.00
A4364	Adhesive, liquid or equal, any type, per oz	0%	110	$0.00
J9267	Injection, paclitaxel, 1 mg	0%	207	$0.00
88341		0%	317	$0.00
77001		0%	74	$0.00
88311		0%	45	$0.00
A4627	Spacer, bag or reservoir, with or without mask, for use with metered dose inhaler	0%	26	$0.00
91303		0%	46	$0.00
29130		0%	13	$0.00
90381		0%	84	$0.00
64415		0%	16	$0.00
G8981	Changing & maintaining body position functional limitation, current status, at therapy episode outset and at reporting intervals	0%	14	$0.00
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	0%	33	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBRANN, TERRANCE (CFO)